8 11, 2016 Harriet Johansson et al., Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial. Breast Cancer Research Diatech Pharmacogenetics2017-08-08T12:52:02+02:00 Read More
26 10, 2016 Annemarie Boleij et al., RAS testing practices and RAS mutation prevalence among patients with metastatic colorectal cancer: results from a Europe-wide survey of pathology centres. BMC Cancer Diatech Pharmacogenetics2017-08-08T12:50:49+02:00 Read More
11 10, 2016 Giovanna De Maglio et al., Management optimization of non small cell lung cancer (NSCLC) specimens. A single institution experience with a multiplexed mass spectrometry approach. Annals of Oncology Diatech Pharmacogenetics2016-10-11T15:56:40+02:00 Read More
11 10, 2016 Annarita Destro et al., The impact of mass spectrometry multigenic platform on the management of metastatic colorectal patients. Annals of Oncology Diatech Pharmacogenetics2017-08-07T16:00:55+02:00 Read More
11 10, 2016 Elisa Chiadini et al., Frequency of driver mutations in EGFR wt NSCLC using mass spectrometry: Experience of Area Vasta Romagna. Annals of Oncology Diatech Pharmacogenetics2016-10-11T15:41:59+02:00 Read More
1 10, 2016 Véronique Quilien et al., P06.13?A low baseline blood neutrophil count and a high percentage of Treg among leucocytes are associated with an increased overall survival of recurrent high-grade glioma patients treated with Bevacizumab. Neuro Oncology Diatech Pharmacogenetics2016-10-01T16:21:08+02:00 Read More
1 10, 2016 Marie Duhamel et al., P06.11 Classification of high-grade glioma using Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry imaging (MALDI MSI): interim results of the GLIOMIC study. Neuro Oncology Diatech Pharmacogenetics2017-12-04T14:36:51+01:00 Read More
1 10, 2016 Daniela Furlan et al., Detection of early genetic and epigenetic alterations in NSCLC by using mass spectrometry and pyrosequencing analysis. Annals of Oncology Diatech Pharmacogenetics2016-10-01T15:32:00+02:00 Read More
22 09, 2016 Andrea Botticelli et al., Degradation Rate of 5-Fluorouracil in Metastatic Colorectal Cancer: A New Predictive Outcome Biomarker? PLOS One Diatech Pharmacogenetics2017-08-08T12:45:17+02:00 Read More
31 08, 2016 Giuseppe Aprile et al., Comparison of the molecular profile of brain metastases from colorectal cancer and corresponding primary tumors. Future Oncology Diatech Pharmacogenetics2016-08-31T11:25:22+02:00 Read More
